glp 1 lean mass loss Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity? GLP-1s, a natural and safer
Description
These findings, and those of future pharmacoepidemiologic analyses, may inform future practice recommendations on the preprocedural protocol for elective endoscopy in the absence of evidence from randomized trials
Slow gastric emptying so food digests more gradually
Huynh G, Runeberg H, Weideman R
Kimonis V, Surampalli A, Wencel M, Gold JA, Cowen NM
/assets/images/provider/photos/2775923.jpeg)
They found that the GLP-1 semaglutide did not improve executive function in MDD
